RNA, 7SL, cytoplasmic 860, pseudogene (RN7SL860P)

RNA, 7SL, cytoplasmic 860, pseudogene (RN7SL860P) is a human pseudogene related to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][5][3]. The 7SL RNA is a key structural and functional component of the SRP involved in targeting secretory and membrane proteins to the endoplasmic reticulum in eukaryotes[3][7]. However, RN7SL860P itself is a pseudogene, meaning it is a non-functional genetic element that resembles the 7SL RNA gene but does not encode a functional RNA or protein product[1][5]. Most human copies of 7SL-like sequences are pseudogenes generated by reverse transcription back into DNA with subsequent loss of function by truncation or mutation[5]. While some pseudogenes in general can produce regulatory RNAs or modulate gene expression, there is no evidence that RN7SL860P has such biological roles, nor is it associated with diseases or targeted by drugs[1][5][6]. Pseudogenes like RN7SL860P are not considered therapeutic targets or biomarkers, but research on pseudogenes as a class suggests some may play roles in gene regulation, small RNA production, or serve as decoys in regulatory networks; these phenomena are not established for this specific locus[4][6]. Summary of analysis: - RN7SL860P is not a therapeutic target, receptor, or functional RNA. - It is a pseudogene, part of the large superfamily of 7SL-derived sequences in the human genome[5]. - There are no drugs, safety concerns, or biomarker uses described. - It should not be considered a druggable molecular target. - There is nothing incorrect about the nomenclature or the target’s definition, though it is not a classical or actionable molecular target for drug discovery or clinical use.

Other names

RN7SL860PRNA, 7SL, cytoplasmic 860, pseudogene

None